Announcements Trials
Browse Landscape

Phase

Phase 2 86Phase 3 33Phase 1 27Phase 1/2 14Phase NA 2Phase 4 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Colorectal Neoplasms 9Breast Neoplasms 5Neoplasms 3Neoplasm Metastasis 3Ovarian Neoplasms 2Liver Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Solid Tumor 1Proteinuria 1Peritoneal Neoplasms 1Non-Squamous Non-Small Cell Lung Cancer 1Locally Advanced Colorectal Cancer 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

niraparib 4olaparib 2apatinib 2Sevoflurane 2Saline Solution 2Propofol 2Carboplatin 2Bevacizumab 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1pazopanib 1palbociclib 1liposomal doxorubicin 1lenvatinib 1gadofosveset trisodium 1fosaprepitant 1ferrous fumarate 1Tranexamic Acid 1Trabectedin 1Sunitinib 1Sodium Chloride 1Pharmacokinetics 1Patient-Specific Modeling 1Pafolacianine 1Paclitaxel 1LY 353381 1Injections 1Indocyanine Green 1Folic Acid 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Ovarian Neoplasms × Bevacizumab × Clear all
NCT01932125 2025-06-26

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Hoffmann-La Roche

Phase 4 Completed
100 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT01706120 2023-03-24

MITO16/MANGO-2

National Cancer Institute, Naples

Phase 4 Unknown
400 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡